DUALASE
Live / Registered — Registered (as of 02 May 2023)
What this means for you
Registered since 02 May 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 May 2029: the §8 declaration of use).
Record
- Serial number
- 90095313
- Registration number
- 7043514
- Mark type
- Word mark
- Filed
- 05 Aug 2020
- Published for opposition
- 12 Oct 2021
- Registered
- 02 May 2023
- Next maintenance filing
- §8 declaration of use, due by 02 May 2029 (grace period to 02 Nov 2029)
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical products development; Pharmaceutical research and development, namely, research in the field of gene editing; Pharmaceutical research services; Biomedical research services; Biotechnology research, namely, in the field of genetic editing; Clinical research in the field of gene editing; Drug discovery services; Medical and scientific research in the field of cancer treatment; Medical and scientific research in the field of treatment of rare genetic diseases and disorders; Medical research; Medical research services, namely, for the treatment of cystic fibrosis and lung cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of genetic editing; Research on the subject of pharmaceuticals, namely, pharmaceuticals to treat genetic disorders, cystic fibrosis and lung cancer; Scientific investigations for medical purposes; Scientific research in the field of oncology; Scientific study and research in the field of oncology; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Medical and scientific research in the field of genetic engineering, namely, platform gene editing technology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Platform as a service (PAAS) featuring computer software platforms for gene editing
Owner
- Specific Biologics Inc., Toronto, Ontario, CA
- Specific Biologics Inc., Toronto, Ontario, CA
- Specific Biologics Inc., Toronto, Ontario, CA
Prosecution history
- 03 Jun 2026 — WITHDRAWAL OF ATTORNEY GRANTED
- 03 Jun 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 02 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Mar 2023 — ASSIGNED TO EXAMINER
- 17 Jan 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jan 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Jan 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jan 2023 — ASSIGNED TO LIE
- 10 Jan 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jul 2022 — NON-FINAL ACTION E-MAILED
- 17 Jul 2022 — SU - NON-FINAL ACTION - WRITTEN